One out of every four patients that are admitted to hospitals to have their seizures evaluated do not have epilepsy. Oftentimes they will have PNES or psychogenic non-epileptic seizures. This is an extremely difficult to diagnose condition and can be quite debilitating for people living with it.
Epilepsy Ireland and FutureNeuro were pleased to recently co-host a Public Seminar to mark International Epilepsy Day.The seminar was for people with epilepsy, their families & carers and highlighted the latest developments in epilepsy research in Ireland and internationally. Below are a selection of speeches from the event.
A Trinity College research group have made a revelation in epilepsy research by becoming the first group to describe a model of mitochondrial epilepsy. This raises the possibility of more effective therapies being developed in the future. The paper which outlines these findings was published in BRAIN, a peer reviewed journal of neurology.
Medtronic plc recently announced both the U.S. launch of Deep Brain Stimulation (DBS) for medically-refractory epilepsy and the first commercially implanted patient at Emory University in Atlanta, Ga. According to the Epilepsy Foundation, as many as 3.4 million Americans have epilepsy, with one-third estimated to be drug resistant.
Professor Stafford Lightman at the University of Bristol began investigating the links between stress and seizures in 2014. This research is vital as although the association between stress and seizures has been noted it is still not fully understood. Lightman’s team from University of Bristol and the University of Exeter placed their focus on the research of cortisol. This is a hormone that is released by the body in response to stress.
Concerns have been raised in the media in recent weeks regarding possible interruptions to the supply of essential medications in Ireland that might occur in the event of a no-deal Brexit. Currently, about 60% of all medications used in Ireland are imported from or pass through Britain.
The HSE, Epilepsy Ireland, OACS Ireland, FACS Forum and Trinity College Dublin have come together to organise the first National Conference on The Consequences of Sodium Valproate (Epilim) in Trinity College on March 22nd 2019.
Support Epilepsy Ireland by getting involved in ‘Purple Day 2019’ and hosting a purple themed event such as a Coffee Morning, Wear Purple to Work/School, Purple Run or create your own event. You could also ask your local town hall to light up purple to raise awareness about epilepsy. To find out more, contact our Purple Day Coordinator Luke Meany on 01 4557500 or firstname.lastname@example.org.
A new study carried out by a University of Iowa research team has used a multidisciplinary strategy that uses a combination of bioinformatics and gene expression profiling to determine a list of close to 90 drugs that are FDA approved and may also be effective as anti-seizure treatment.
Perhaps best-known as the patron saint of love and lovers, St Valentine is also the patron saint of epilepsy.